Summary
Definition
History and exam
Key diagnostic factors
- headache
- neurologic deficit
- seizure
- history of radiation exposure
Other diagnostic factors
- family history of brain tumor or neurofibromatosis 2 (NF2)
- history of breast cancer
- history of exogenous hormone exposure
- cognitive deficit
- vertigo/dizziness
Risk factors
- ionizing radiation
- genetic predisposition
- hormones: endogenous and exogenous
- head trauma
Diagnostic tests
1st tests to order
- MRI brain or spine with and without contrast
Tests to consider
- CT brain or spine
- somatostatin receptor PET/CT
- cerebral angiography
- histopathology of surgical resection
Treatment algorithm
good surgical candidate
poor surgical candidate
recurrent or progressive tumor following initial treatment
Contributors
Authors
Stephen T. Magill, MD, PhD
Assistant Professor
Lou and Jean Malnati Brain Tumor Institute
Robert Lurie Comprehensive Cancer Center
Department of Neurological Surgery
Northwestern University Feinberg School of Medicine
Chicago
IL
Disclosures
STM has authored several articles cited in this topic.
Acknowledgements
Dr Stephen T. Magill would like to gratefully acknowledge Professor William T. Couldwell and Dr Jayson A. Neil, previous contributors to this topic.
Disclosures
WTC is an author of several references cited in this topic. JAN declares that he has no competing interests.
Peer reviewers
Marc Chamberlain, MD
Professor of Neurology
Moffitt Cancer Center and Research Institute
University of Washington
Seattle
WA
Divulgaciones
MC is an author of several references cited in this topic.
Ian McCutcheon, MD
Professor of Neurosurgery
The University of Texas M. D. Anderson Cancer Center
Houston
TX
Divulgaciones
IM declares that he has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
World Health Organization Classification of Tumours Editorial Board. WHO classification of tumours of the central nervous system. 5th Edition. France: IARC; 2021.
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-51.Texto completo Resumen
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: central nervous system cancers [internet publication].Texto completo
Goldbrunner R, Stavrinou P, Jenkinson MD, et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021 Nov 2;23(11):1821-34.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Dural metastasis
- Granuloma
- IgG4-related disease
Más DiferencialesGuías de práctica clínica
- NCCN guidelines: central nervous system cancers
- American College of Radiology (ACR) appropriateness criteria: brain tumors
Más Guías de práctica clínica
Inicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad